Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Drug Resistance

  Free Subscription


28.06.2021

58 Antimicrob Agents Chemother
5 Clin Infect Dis
1 Emerg Infect Dis
1 Infect Control Hosp Epidemiol
3 Int J Antimicrob Agents
22 J Antimicrob Chemother
5 J Clin Microbiol
10 J Infect Chemother
1 J Med Microbiol
4 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Antimicrob Agents Chemother

  1. FERREIRA S, Silva AL, Tomas J, Mateus C, et al
    Characterization of AreABC, an RND-type efflux system involved in antimicrobial resistance of Aliarcobacter butzleri.
    Antimicrob Agents Chemother. 2021 Jun 21:AAC0072921. doi: 10.1128/AAC.00729.
    PubMed         Abstract available

  2. STAPLETON AE, Wagenlehner FME, Mulgirigama A, Twynholm M, et al
    E. coli Resistance to Fluoroquinolones in Community-Acquired Uncomplicated Urinary Tract Infection In Women: A Systematic Review.
    Antimicrob Agents Chemother. 2020 Aug 3. pii: AAC.00862.
    PubMed         Abstract available

  3. LIM HJ, Shin JH, Kim MN, Yong D, et al
    Evaluation of Two Commercial Broth Microdilution Methods Using Different Interpretive Criteria for the Detection of Molecular Mechanisms of Acquired Azole and Echinocandin Resistance in Four Common Candida Species.
    Antimicrob Agents Chemother. 2020 Sep 8. pii: AAC.00740.
    PubMed         Abstract available

  4. CACACI M, Menchinelli G, Torelli R, Sanglard D, et al
    Fenticonazole against Fluconazole-Resistant Candida Species: New In Vitro Activity Data.
    Antimicrob Agents Chemother. 2020 Sep 28. pii: AAC.01459.
    PubMed         Abstract available

  5. ZHOU YF, Liu P, Dai SH, Sun J, et al
    Activity of tigecycline or colistin in combination with zidovudine against Escherichia coli harboring tet(X) and mcr-1.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01172.
    PubMed         Abstract available

  6. SERRANO-LOBO J, Gomez A, Sanchez-Yebra W, Fajardo M, et al
    Azole and amphotericin B minimum inhibitory concentrations against Aspergillus fumigatus: high agreement between spectrophotometric and visual readings using the EUCAST 9.3.2 procedure.
    Antimicrob Agents Chemother. 2020 Oct 5. pii: AAC.01693.
    PubMed         Abstract available

  7. NAVARRO-RODRIGUEZ P, Lopez-Fernandez L, Martin-Vicente A, Guarro J, et al
    ERG11 polymorphism in voriconazole-resistant Candida tropicalis. Weak role of ERG11 expression, ergosterol content and membrane permeability.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.00325.
    PubMed         Abstract available

  8. BING J, Hu T, Zheng Q, Munoz JF, et al
    Experimental evolution identifies adaptive aneuploidy as a mechanism of fluconazole resistance in Candida auris.
    Antimicrob Agents Chemother. 2020 Oct 19. pii: AAC.01466.
    PubMed         Abstract available

  9. PHAM CD, Nash E, Liu H, Schmerer MW, et al
    Atypical Mutation in Neisseria gonorrhoeae 23S rRNA Associated with High-Level Azithromycin Resistance.
    Antimicrob Agents Chemother. 2020 Nov 2. pii: AAC.00885.
    PubMed         Abstract available

  10. BURNARD D, Robertson G, Henderson A, Falconer C, et al
    Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible In Vitro to Cefiderocol, a Siderophore Cephalosporin.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  11. MOTOS A, Li Bassi G, Pagliara F, Fernandez-Barat L, et al
    Short-Term Effects of Appropriate Empirical Antimicrobial Treatment with Ceftolozane/Tazobactam in a Swine Model of Nosocomial Pneumonia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  12. YIN Y, Zhang H, Zhang Y, Hu C, et al
    Fungal Zn(II)2Cys6 Transcription Factor ADS-1 Regulates Drug Efflux and Ergosterol Metabolism under Antifungal Azole Stress.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  13. PYBUS CA, Felder-Scott C, Obuekwe V, Greenberg DE, et al
    Cefiderocol Retains Antibiofilm Activity in Multidrug-Resistant Gram-Negative Pathogens.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  14. CAO D, Wu R, Dong S, Wang F, et al
    Azole resistance in environmental Aspergillus fumigatus isolates from China: A five-year survey from 2014 to 2018.
    Antimicrob Agents Chemother. 2020 Jul 27. pii: AAC.00904.
    PubMed         Abstract available

  15. ARASTEHFAR A, Daneshnia F, Hilmioglu-Polat S, Fang W, et al
    First report of candidemia clonal outbreak caused by emerging fluconazole-resistant Candida parapsilosis isolates harboring Y132F and/or Y132F+K143R in Turkey.
    Antimicrob Agents Chemother. 2020 Jul 20. pii: AAC.01001.
    PubMed         Abstract available

  16. ROUNDTREE MT, Juvvadi PR, Shwab EK, Cole DC, et al
    Aspergillus fumigatus Cyp51A and Cyp51B Proteins are Compensatory in Function and Localize Differentially in Response to Antifungals and Cell Wall Inhibitors.
    Antimicrob Agents Chemother. 2020 Jul 13. pii: AAC.00735.
    PubMed         Abstract available

  17. BROWN MM, Kwiecinski JM, Mejia Cruz L, Shahbandi A, et al
    Novel peptide from commensal Staphylococcus simulans blocks MRSA quorum sensing and protects host skin from damage.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00172.
    PubMed         Abstract available

  18. ALMEIDA LM, Lebreton F, Gaca A, Bispo PM, et al
    Transferable Resistance Gene optrA in Enterococcus faecalis from Swine in Brazil.
    Antimicrob Agents Chemother. 2020 Apr 6. pii: AAC.00142.
    PubMed         Abstract available

  19. ZHAO L, Yan Y, Dai Q, Li X, et al
    Development of Novel Anti-influenza Thiazolides with Relatively Broad-spectrum Antiviral Potentials.
    Antimicrob Agents Chemother. 2020 Apr 20. pii: AAC.00222.
    PubMed         Abstract available

  20. KIM D, Yoon EJ, Hong JS, Lee H, et al
    Impact of vanA-positive Enterococcus faecium exhibiting diverse susceptibility phenotypes to glycopeptides on 30-day mortality of patients with a bloodstream infection.
    Antimicrob Agents Chemother. 2020 Apr 27. pii: AAC.02180.
    PubMed         Abstract available

  21. ADAMS SE, Lugovtsev VY, Kan A, Bovin NV, et al
    Laninamivir-Interferon-lambda1 Combination Treatment Promotes Resistance by Influenza A Virus More Rapidly Than Laninamivir Alone.
    Antimicrob Agents Chemother. 2020 May 11. pii: AAC.00301.
    PubMed         Abstract available

  22. MACEDO D, Brito Devoto T, Pola S, Finquelievich JL, et al
    A novel combination of CYP51A mutations confers pan-azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.02501.
    PubMed         Abstract available

  23. ZILBERBERG MD, Nathanson BH, Sulham K, Shorr AF, et al
    Antimicrobial susceptibility and cross-resistance patterns among common complicated urinary tract infections in US hospitals, 2013-2018.
    Antimicrob Agents Chemother. 2020 May 18. pii: AAC.00346.
    PubMed         Abstract available

  24. COHEN KA, Stott KE, Munsamy V, Manson AL, et al
    Evidence for expanding the role of streptomycin in the management of drug-resistant M. tuberculosis.
    Antimicrob Agents Chemother. 2020 Jun 15. pii: AAC.00860.
    PubMed         Abstract available

  25. PAIS P, California R, Galocha M, Viana R, et al
    Candida glabrata Transcription Factor Rpn4 Mediates Fluconazole Resistance Through Regulation of Ergosterol Biosynthesis and Plasma Membrane Permeability.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00554.
    PubMed         Abstract available

  26. KHALIFA HO, Arai T, Majima H, Watanabe A, et al
    Genetic Basis of Azole and Echinocandin Resistance in Clinical Candida glabrata in Japan.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00783.
    PubMed         Abstract available

  27. SAFI H, Lingaraju S, Ma S, Husain S, et al
    Rapidly-correcting Frameshift Mutations in the Mycobacterium tuberculosis orn Gene Produce Reversible Ethambutol Resistance and Small Colony Variant Morphology.
    Antimicrob Agents Chemother. 2020 Jun 22. pii: AAC.00213.
    PubMed         Abstract available

  28. SMITH SJ, Zhao XZ, Passos DO, Lyumkis D, et al
    HIV-1 Integrase Inhibitors that are active against Drug-Resistant Integrase Mutants.
    Antimicrob Agents Chemother. 2020 Jun 29. pii: AAC.00611.
    PubMed         Abstract available

  29. KHABTHANI S, Hamel M, Baron SA, Diene SM, et al
    fosM, a New Family of Fosfomycin Resistance Genes Identified in Bacterial Species Isolated from Human Microbiota.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  30. RUBIO AM, Kline EG, Jones CE, Chen L, et al
    In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  31. MIRA PM, Ostman B, Guzman-Cole C, Sindi S, et al
    Adaptive Processes Change as Multiple Functions Evolve.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  32. SMITH NM, Ang A, Tan F, Macias K, et al
    Interaction of Staphylococcus aureus and Acinetobacter baumannii during in vitro beta-lactam exposure.
    Antimicrob Agents Chemother. 2021 Jan 25. pii: AAC.02414.
    PubMed         Abstract available

  33. NAKAMURA R, Oota M, Matsumoto S, Sato T, et al
    In Vitro Activity and In Vivo Efficacy of Cefiderocol against Stenotrophomonas maltophilia.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  34. BOOT W, Schmid T, D'Este M, Guillaume O, et al
    A Hyaluronic Acid Hydrogel Loaded with Gentamicin and Vancomycin Successfully Eradicates Chronic Methicillin-Resistant Staphylococcus aureus Orthopedic Infection in a Sheep Model.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  35. MASUKO A, Takata I, Fujita K, Okumura H, et al
    In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  36. WEI Y, Sluis-Cremer N
    Mutations in the HIV-1 3'-Polypurine Tract and Integrase Strand-Transfer Inhibitor Resistance.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.02432.
    PubMed         Abstract available

  37. ARDIZZONI E, Ariza E, Mulengwa D, Mpala Q, et al
    Thin layer agar-based direct phenotypic drug-susceptibility testing on sputum in Eswatini rapidly detects Mycobacterium tuberculosis growth and rifampicin resistance, otherwise missed by WHO endorsed diagnostic tests.
    Antimicrob Agents Chemother. 2021 Mar 15. pii: AAC.02263.
    PubMed         Abstract available

  38. MOIRANGTHEM R, Kumar K, Kaur R
    Two Functionally Redundant FK506-Binding Proteins Regulate Multidrug Resistance Gene Expression and Govern Azole Antifungal Resistance.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  39. MENGUAL-CHULIA B, Alonso-Cordero A, Cano L, Del Mar Mosquera M, et al
    Surveillance of Influenza A resistance to polymerase complex inhibitors by whole genome analysis, 2016-17, 2017-18 and 2018-19 Seasons, Eastern Spain.
    Antimicrob Agents Chemother. 2021 Mar 29. pii: AAC.02718.
    PubMed         Abstract available

  40. DESNOS-OLLIVIER M, Lortholary O, Bretagne S, Dromer F, et al
    Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare Species.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  41. SOLIMAN AM, Ramadan H, Zarad H, Sugawara Y, et al
    Coproduction of Tet(X7) Conferring High-Level Tigecycline Resistance, Fosfomycin FosA4, and Colistin Mcr-1.1 in Escherichia coli Strains from Chickens in Egypt.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  42. POULSEN JS, Madsen AM, White JK, Nielsen JL, et al
    Physiological responses of Aspergillus niger challenged with itraconazole.
    Antimicrob Agents Chemother. 2021 Apr 5. pii: AAC.02549.
    PubMed         Abstract available

  43. DIAZ-GARCIA J, Mesquida A, Sanchez-Carrillo C, Reigadas E, et al
    Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  44. CAMP J, Schuster S, Vavra M, Schweigger T, et al
    Limited Multidrug Resistance Efflux Pump Overexpression among Multidrug-Resistant Escherichia coli Strains of ST131.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  45. CHENG J, Yan J, Reyna Z, Slarve M, et al
    Synergistic Rifabutin and Colistin Reduce Emergence of Resistance When Treating Acinetobacter baumannii.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  46. YANG J, Liu L, Feng Y, He D, et al
    Potential Mobilization of mcr-10 by an Integrative Mobile Element via Site-Specific Recombination in Cronobacter sakazakii.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  47. ASADZADEH M, Dashti M, Ahmad S, Alfouzan W, et al
    Whole genome and targeted-amplicon sequencing of fluconazole-susceptible and -resistant Candida parapsilosis isolates from Kuwait reveals a previously undescribed N1132D polymorphism in CDR1.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01633.
    PubMed         Abstract available

  48. OLIVER MB, Fong K, Certain L, Spivak ES, et al
    Validation of a Community-Acquired Pneumonia Score To Improve Empiric Antibiotic Selection at an Academic Medical Center.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  49. VIJAY S, Nhung HN, Bao NLH, Thu DDA, et al
    Most-probable number based minimum duration of killing assay for determining the spectrum of rifampicin susceptibility in clinical M. tuberculosis isolates.
    Antimicrob Agents Chemother. 2020 Nov 30. pii: AAC.01439.
    PubMed         Abstract available

  50. MARGOT N, Ram R, Rhee M, Callebaut C, et al
    Absence of Lenacapavir (GS-6207) Phenotypic Resistance in HIV Gag Cleavage Site Mutants and in Isolates with Resistance to Existing Drug Classes.
    Antimicrob Agents Chemother. 2020 Dec 7. pii: AAC.02057.
    PubMed         Abstract available

  51. CHU S, Long L, Sherif R, McCormick TS, et al
    A second generation fungerp analog SCY-247, shows potent in vitro activity against Candida auris and other clinically relevant fungal isolates.
    Antimicrob Agents Chemother. 2020 Dec 14. pii: AAC.01988.
    PubMed         Abstract available

  52. WANG G, Brunel JM, Bolla JM, Van Bambeke F, et al
    The Polyaminoisoprenyl Potentiator NV716 Revives Old Disused Antibiotics against Intracellular Forms of Infection by Pseudomonas aeruginosa.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  53. FANG Y, Kirsch JR, Li L, Brooks SA, et al
    Deimmunized Lysostaphin Synergizes with Small-Molecule Chemotherapies and Resensitizes Methicillin-Resistant Staphylococcus aureus to beta-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  54. ATTERBY C, Nykvist M, Lustig U, Andersson DI, et al
    Selection of Resistant Bacteria in Mallards Exposed to Subinhibitory Concentrations of Ciprofloxacin in Their Water Environment.
    Antimicrob Agents Chemother. 2021;65.
    PubMed         Abstract available

  55. DU W, Zhai P, Wang T, Bromley MJ, et al
    The C2H2 Transcription Factor SltA Contributes to Azole Resistance by Coregulating the Expression of the Drug Target Erg11A and the Drug Efflux Pump Mdr1 in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.01839.
    PubMed         Abstract available

  56. CAZER CL, Westblade LF, Simon MS, Magleby R, et al
    Analysis of multidrug resistance in Staphylococcus aureus with a machine learning generated antibiogram.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02132.
    PubMed         Abstract available

  57. PFALLER MA, Messer SA, Deshpande LM, Rhomberg PR, et al
    Evaluation of Synergistic Activity of Isavuconazole or Voriconazole plus Anidulafungin and the Occurrence and Genetic Characterisation of Candida auris Detected in a Surveillance Program.
    Antimicrob Agents Chemother. 2021 Jan 11. pii: AAC.02031.
    PubMed         Abstract available

  58. PRATER AG, Mehta HH, Beabout K, Supandy A, et al
    Daptomycin resistance in Enterococcus faecium can be delayed by disruption of the LiaFSR stress response pathway.
    Antimicrob Agents Chemother. 2021 Jan 19. pii: AAC.01317.
    PubMed         Abstract available


    Clin Infect Dis

  59. KAYE KS, Gupta V, Mulgirigama A, Joshi AV, et al
    Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011-2019: Rising ESBL Strains and Impact on Patient Management.
    Clin Infect Dis. 2021 Jun 18. pii: 6304915. doi: 10.1093.
    PubMed         Abstract available

  60. KARLOWSKY JA, Lob SH, Raddatz J, DePestel DD, et al
    In Vitro Activity of Imipenem/Relebactam and Ceftolozane/Tazobactam Against Clinical Isolates of Gram-negative Bacilli With Difficult-to-Treat Resistance and Multidrug-resistant Phenotypes-Study for Monitoring Antimicrobial Resistance Trends, United S
    Clin Infect Dis. 2021;72:2112-2120.
    PubMed         Abstract available

  61. AL-HASAN MN
    Gram-negative Bacteria With Difficult-to-Treat Resistance: A Moving Target.
    Clin Infect Dis. 2021;72:2121-2123.
    PubMed        

  62. KENDALL EA, Kitonsa PJ, Nalutaaya A, Kamoga CE, et al
    The spectrum of tuberculosis disease in an urban Ugandan community and its health facilities.
    Clin Infect Dis. 2020 Dec 6. pii: 6024999. doi: 10.1093/cid/ciaa1824.
    PubMed         Abstract available

  63. STEWART AG, Satlin MJ, Schlebusch S, Isler B, et al
    Completing the Picture-Capturing the Resistome in Antibiotic Clinical Trials.
    Clin Infect Dis. 2021;72:e1122-e1129.
    PubMed         Abstract available


    Emerg Infect Dis

  64. ALVAREZ-NARVAEZ S, Giguere S, Cohen N, Slovis N, et al
    Spread of Multidrug-Resistant Rhodococcus equi, United States.
    Emerg Infect Dis. 2021;27:529-537.
    PubMed         Abstract available


    Infect Control Hosp Epidemiol

  65. RYNKIEWICH KR, Makhija J, Froilan MCM, Benson EC, et al
    Healthcare personnel experiences implementing carbapenem-resistant Enterobacterales infection control measures at a ventilator-capable skilled nursing facility-A qualitative analysis.
    Infect Control Hosp Epidemiol. 2021 Jun 21:1-7. doi: 10.1017/ice.2021.
    PubMed         Abstract available


    Int J Antimicrob Agents

  66. MOOR J, Aebi S, Rickli S, Mostacci N, et al
    Dynamics of extended-spectrum cephalosporin-resistant E. coli in pig farms: A longitudinal study.
    Int J Antimicrob Agents. 2021 Jun 19:106382.
    PubMed         Abstract available

  67. CHAIYACHAT P, Chaiprasert A, Nonghanphithak D, Smithtikarn S, et al
    Whole-genome analysis of drug-resistant Mycobacterium tuberculosis reveals novel mutations associated with fluoroquinolone resistance.
    Int J Antimicrob Agents. 2021 Jun 20:106385.
    PubMed         Abstract available

  68. LEE YL, Ko WC, Lee WS, Lu PL, et al
    In vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline, and other comparative agents against carbapenem-nonsusceptible Enterobacterales: Results from the Surveillance of Multicenter Antimicrobial Res
    Int J Antimicrob Agents. 2021 Jun 21:106377.
    PubMed         Abstract available


    J Antimicrob Chemother

  69. EGAN SA, Shore AC, O'Connell B, Brennan GI, et al
    Linezolid resistance in Enterococcus faecium and Enterococcus faecalis from hospitalized patients in Ireland: high prevalence of the MDR genes optrA and poxtA in isolates with diverse genetic backgrounds.
    J Antimicrob Chemother. 2020 Mar 4. pii: 5780432. doi: 10.1093.
    PubMed         Abstract available

  70. VAN RIE A, Whitfield MG, De Vos E, Scott L, et al
    Discordances between molecular assays for rifampicin resistance in Mycobacterium tuberculosis: frequency, mechanisms and clinical impact.
    J Antimicrob Chemother. 2020 Feb 4. pii: 5722231. doi: 10.1093.
    PubMed         Abstract available

  71. CEBALLOS GARZON A, Amado D, Robert E, Parra Giraldo CM, et al
    Impact of calmodulin inhibition by fluphenazine on susceptibility, biofilm formation and pathogenicity of caspofungin-resistant Candida glabrata.
    J Antimicrob Chemother. 2020 Feb 3. pii: 5721438. doi: 10.1093.
    PubMed         Abstract available

  72. ALVAREZ-VEGA M, Boga JA, Fernandez-Suarez J, Martinez-Sela M, et al
    Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments-authors' response.
    J Antimicrob Chemother. 2020 Jan 16. pii: 5707452. doi: 10.1093.
    PubMed        

  73. SITTERLE E, Coste AT, Obadia T, Maufrais C, et al
    Large-scale genome mining allows identification of neutral polymorphisms and novel resistance mutations in genes involved in Candida albicans resistance to azoles and echinocandins.
    J Antimicrob Chemother. 2020 Jan 10. pii: 5700447. doi: 10.1093.
    PubMed         Abstract available

  74. PARENT-MICHAUD M, Dufresne PJ, Fournier E, Folch B, et al
    Prevalence and mechanisms of azole resistance in clinical isolates of Aspergillus section Fumigati species in a Canadian tertiary care centre, 2000 to 2013.
    J Antimicrob Chemother. 2019 Dec 31. pii: 5692254. doi: 10.1093.
    PubMed         Abstract available

  75. RUTH MM, Koeken VACM, Pennings LJ, Svensson EM, et al
    Is there a role for tedizolid in the treatment of non-tuberculous mycobacterial disease?
    J Antimicrob Chemother. 2019 Dec 30. pii: 5690335. doi: 10.1093.
    PubMed         Abstract available

  76. PEREZ-ALBA E, Bocanegra-Ibarias P, Garza-Gonzalez E, Martinez-Ponce de Leon AR, et al
    Comment on: Multidrug-resistant Acinetobacter meningitis in neurosurgical patients with intraventricular catheters: assessment of different treatments.
    J Antimicrob Chemother. 2019 Oct 26. pii: 5607519. doi: 10.1093.
    PubMed        

  77. SATISHKUMAR N, Alexander JAN, Poon R, Buggeln E, et al
    PBP4-mediated beta-lactam resistance among clinical strains of Staphylococcus aureus.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307153. doi: 10.1093.
    PubMed         Abstract available

  78. LU HF, Tsai YC, Li LH, Lin YT, et al
    Role of AzoR, a LysR-type transcriptional regulator, in SmeVWX pump-mediated antibiotic resistance in Stenotrophomonas maltophilia.
    J Antimicrob Chemother. 2021 Jun 21. pii: 6307154. doi: 10.1093.
    PubMed         Abstract available

  79. GUERIN F, Sassi M, Dejoies L, Zouari A, et al
    Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium.
    J Antimicrob Chemother. 2020 Apr 11. pii: 5819175. doi: 10.1093.
    PubMed         Abstract available

  80. DEJOIES L, Boukthir S, Pean de Ponfilly G, Le Guen R, et al
    Performance of commercial methods for linezolid susceptibility testing of Enterococcus faecium and Enterococcus faecalis.
    J Antimicrob Chemother. 2020 May 25. pii: 5843866. doi: 10.1093.
    PubMed         Abstract available

  81. OUESLATI S, Volland H, Cattoir V, Bernabeu S, et al
    Development and validation of a lateral flow immunoassay for rapid detection of VanA-producing enterococci.
    J Antimicrob Chemother. 2021;76:146-151.
    PubMed         Abstract available

  82. HUA X, Moran RA, Xu Q, He J, et al
    Acquisition of a genomic resistance island (AbGRI5) from global clone 2 through homologous recombination in a clinical Acinetobacter baumannii isolate.
    J Antimicrob Chemother. 2021;76:65-69.
    PubMed         Abstract available

  83. CHERNY SS, Nevo D, Baraz A, Baruch S, et al
    Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling.
    J Antimicrob Chemother. 2021;76:239-248.
    PubMed         Abstract available

  84. SALADINI F, Giammarino F, Hosseini BA, Giannini A, et al
    In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations.
    J Antimicrob Chemother. 2021;76:130-134.
    PubMed         Abstract available

  85. WENK BM, Mbunkah HA, Nsanwe NN, Mbu ET, et al
    Prevalence of integrase strand transfer inhibitor resistance mutations in antiretroviral-naive HIV-1-infected individuals in Cameroon.
    J Antimicrob Chemother. 2021;76:124-129.
    PubMed         Abstract available

  86. NOVAK-FRAZER L, Anees-Hill SP, Hassan D, Masania R, et al
    Deciphering Aspergillus fumigatus cyp51A-mediated triazole resistance by pyrosequencing of respiratory specimens.
    J Antimicrob Chemother. 2020 Aug 30. pii: 5899263. doi: 10.1093.
    PubMed         Abstract available

  87. SIOPI M, Rivero-Menendez O, Gkotsis G, Panara A, et al
    Nationwide surveillance of azole-resistant Aspergillus fumigatus environmental isolates in Greece: detection of pan-azole resistance associated with the TR46/Y121F/T289A cyp51A mutation.
    J Antimicrob Chemother. 2020 Aug 20. pii: 5894665. doi: 10.1093.
    PubMed         Abstract available

  88. MAITRA A, Evangelopoulos D, Chrzastek A, Martin LT, et al
    Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis.
    J Antimicrob Chemother. 2020 Aug 13. pii: 5892302. doi: 10.1093.
    PubMed         Abstract available

  89. FREITAS AR, Tedim AP, Duarte B, Elghaieb H, et al
    Linezolid-resistant (Tn6246::fexB-poxtA) Enterococcus faecium strains colonizing humans and bovines on different continents: similarity without epidemiological link.
    J Antimicrob Chemother. 2020 Jul 1. pii: 5865502. doi: 10.1093.
    PubMed         Abstract available

  90. BUIL JB, Bruggemann RJM, Bedin Denardi L, Melchers WJG, et al
    In vitro interaction of isavuconazole and anidulafungin against azole-susceptible and azole-resistant Aspergillus fumigatus isolates.
    J Antimicrob Chemother. 2020 Jun 9. pii: 5855124. doi: 10.1093.
    PubMed         Abstract available


    J Clin Microbiol

  91. PICHON M, Pichard B, Barrioz T, Plouzeau C, et al
    Diagnostic accuracy of a non-invasive test for the detection of Helicobacter pylori and resistance to clarithromycin in stool by Real-Time PCR Amplidiag((R)) H. pylori + ClariR assay.
    J Clin Microbiol. 2020 Jan 29. pii: JCM.01787-19. doi: 10.1128/JCM.01787.
    PubMed         Abstract available

  92. GARGIS AS, Yoo BB, Lonsway DR, Anderson K, et al
    Difficult-to-Detect Staphylococcus aureus: mecA-positive Isolates Associated with Oxacillin and Cefoxitin False-Susceptible Results.
    J Clin Microbiol. 2020 Jan 29. pii: JCM.02038-19. doi: 10.1128/JCM.02038.
    PubMed         Abstract available

  93. CATANZARO DG, Colman RE, Linger Y, Georghiou SB, et al
    Laboratory evaluation of a lateral-flow cell for molecular detection of first-line and second-line anti-tuberculosis drug resistance.
    J Clin Microbiol. 2020 Aug 19. pii: JCM.01417-20. doi: 10.1128/JCM.01417.
    PubMed         Abstract available

  94. YU LS, Rodriguez-Manzano J, Moser N, Moniri A, et al
    Rapid detection of azole-resistant Aspergillus fumigatus in clinical and environmental isolates using lab-on-a-chip diagnostic system.
    J Clin Microbiol. 2020 Sep 9. pii: JCM.00843-20. doi: 10.1128/JCM.00843.
    PubMed         Abstract available

  95. SORIA ME, Garcia-Crespo C, Martinez-Gonzalez B, Vazquez-Sirvent L, et al
    Amino acid substitutions associated with treatment failure of hepatitis C virus infection.
    J Clin Microbiol. 2020 Sep 30. pii: JCM.01985-20. doi: 10.1128/JCM.01985.
    PubMed         Abstract available


    J Infect Chemother

  96. OTA Y, Furuhashi K, Hayashi W, Hirai N, et al
    Daptomycin resistant Enterococcus faecalis has a mutation in liaX, which encodes a surface protein that inhibits the LiaFSR systems and cell membrane remodeling.
    J Infect Chemother. 2021;27:90-93.
    PubMed         Abstract available

  97. KATO T, Tanaka I, Seyama Y, Sekikawa R, et al
    The effectiveness of prescription support and treatment reporting system on the appropriate usage of oral third-generation cephalosporins.
    J Infect Chemother. 2021;27:419-423.
    PubMed         Abstract available

  98. KAGAMI K, Ishiguro N, Yamada T, Niinuma Y, et al
    Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant gram-negative bacilli.
    J Infect Chemother. 2021;27:473-479.
    PubMed         Abstract available

  99. HAMASUNA R, Aono H, Kawaguchi K, Matsumoto M, et al
    Sensitivity of a transcription-mediated amplification method (Aptima Mycoplasma genitalium assay) to detect M. genitalium in vitro.
    J Infect Chemother. 2021;27:573-577.
    PubMed         Abstract available

  100. ISHIWADA N, Fujimaki K, Matsumoto T, Kiyota H, et al
    Nationwide surveillance of bacterial pathogens isolated from children conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in
    J Infect Chemother. 2021;27:139-150.
    PubMed         Abstract available

  101. TAKAZONO T, Ito Y, Tashiro M, Nakano Y, et al
    Transition of triazole-resistant Aspergillus fumigatus isolates in a Japanese tertiary hospital and subsequent genetic analysis.
    J Infect Chemother. 2021;27:537-539.
    PubMed         Abstract available

  102. OISHI T, Saito A, Fukuda Y, Kato A, et al
    Analysis of risk factors for multidrug-resistant pathogens and appropriate treatment indications for pneumonia in children with neurologic impairment.
    J Infect Chemother. 2021;27:342-347.
    PubMed         Abstract available

  103. TSUNODA R, Usui M, Tagaki C, Fukuda A, et al
    Genetic characterization of coliform bacterial isolates from environmental water in Thailand.
    J Infect Chemother. 2021;27:722-728.
    PubMed         Abstract available

  104. KHALIFA HO, Arai T, Majima H, Watanabe A, et al
    Evaluation of Surveyor nuclease for rapid identification of FKS genes mutations in Candida glabrata.
    J Infect Chemother. 2021;27:834-839.
    PubMed         Abstract available

  105. NAKASE K, Nakanishi-Yamasaki M, Harada K, Koizumi J, et al
    Antimicrobial activity and additive effect of the modified Gingyo-san with antimicrobials against Helicobacter pylori.
    J Infect Chemother. 2021;27:957-961.
    PubMed         Abstract available


    J Med Microbiol

  106. ISHIGURO N, Sato R, Kikuta H, Nakanishi M, et al
    P1 gene of Mycoplasma pneumoniae isolated from 2016 to 2019 and relationship between genotyping and macrolide resistance in Hokkaido, Japan.
    J Med Microbiol. 2021;70.
    PubMed         Abstract available


    PLoS One

  107. REGASA DADI B, Solomon Z, Tesfaye M
    Vancomycin resistant Enterococci and its associated factors among HIV infected patients on anti-retroviral therapy in Ethiopia.
    PLoS One. 2021;16:e0251727.
    PubMed         Abstract available

  108. HLASHWAYO DF, Sigauque B, Noormahomed EV, Afonso SMS, et al
    A systematic review and meta-analysis reveal that Campylobacter spp. and antibiotic resistance are widespread in humans in sub-Saharan Africa.
    PLoS One. 2021;16:e0245951.
    PubMed         Abstract available

  109. SKENDER K, Singh V, Stalsby-Lundborg C, Sharma M, et al
    Trends and patterns of antibiotic prescribing at orthopedic inpatient departments of two private-sector hospitals in Central India: A 10-year observational study.
    PLoS One. 2021;16:e0245902.
    PubMed         Abstract available

  110. HARIMURTI K, Saldi SRF, Dewiasty E, Alfarizi T, et al
    Streptococcus pneumoniae carriage and antibiotic susceptibility among Indonesian pilgrims during the Hajj pilgrimage in 2015.
    PLoS One. 2021;16:e0246122.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  111. CHE Y, Yang Y, Xu X, Brinda K, et al
    Conjugative plasmids interact with insertion sequences to shape the horizontal transfer of antimicrobial resistance genes.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: